GJA1 and arrhythmogenic right ventricular cardiomyopathy: Moreover, treatment with a selective peptide-based blocker of Cx43 HCs normalized arrhythmogenic Ca2+ dynamics—suggestive of a role for HCs in the formative stages of ARVC pathogenesis.